These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37931687)

  • 21. Prognostic value of CD45 transcriptional expression in head and neck cancer.
    Camacho M; Agüero A; Sumarroca A; López L; Pavón MÁ; Avilés-Jurado FX; García J; Quer M; León X
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):225-232. PubMed ID: 29177949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence.
    Ganci F; Sacconi A; Manciocco V; Covello R; Benevolo M; Rollo F; Strano S; Valsoni S; Bicciato S; Spriano G; Muti P; Fontemaggi G; Blandino G
    Mod Pathol; 2017 Oct; 30(10):1387-1401. PubMed ID: 28731048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management of recurrent cutaneous squamous cell carcinoma of the head and neck after definitive surgery and radiotherapy.
    Toppi J; Tham YS; Webb A; Henderson MA; Rischin D; Magarey MJR
    ANZ J Surg; 2020 Jul; 90(7-8):1391-1395. PubMed ID: 32627359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
    Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
    Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy.
    Fu X; Chen S; Chen W; Yang Z; Song M; Li H; Zhang H; Yao F; Su X; Liu T; Yang AK
    Oral Oncol; 2018 Sep; 84():20-24. PubMed ID: 30115471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.
    Akervall J; Nandalur S; Zhang J; Qian CN; Goldstein N; Gyllerup P; Gardinger Y; Alm J; Lorenc K; Nilsson K; Resau J; Wilson G; Teh B
    Eur J Cancer; 2014 Feb; 50(3):570-81. PubMed ID: 24332450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation.
    Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM
    Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study.
    Guan Z; Liu J; Zheng L
    Sci Rep; 2024 Mar; 14(1):6304. PubMed ID: 38491080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
    Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
    Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of mutant-type p53 expression in squamous cell carcinoma of the head and neck during radiation therapy and its clinical significance: comparison of an immunohistochemical method and PCR-SSCP assay.
    Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
    Oncol Rep; 1998; 5(5):1053-9. PubMed ID: 9683807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparisons of the clinical outcomes of different postoperative radiation strategies for treatment of head and neck squamous cell carcinoma.
    Makita C; Kodaira T; Daimon T; Tachibana H; Tomita N; Koide Y; Koide Y; Fukuda Y; Nishikawa D; Suzuki H; Hanai N; Hasegawa Y
    Jpn J Clin Oncol; 2017 Dec; 47(12):1141-1150. PubMed ID: 29036621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of specific survival and local control through a recursive partitioning analysis in patients with head and neck carcinoma.
    León X; Rodriguez C; Rovira C; García J; López M; Quer M
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):131-139. PubMed ID: 31060733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
    Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
    Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma.
    Pardo L; Valero C; López M; García J; Camacho M; Quer M; León X
    Auris Nasus Larynx; 2017 Jun; 44(3):313-318. PubMed ID: 27401121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postoperative radiotherapy with cetuximab for head and neck squamous cell carcinoma patients at high risk of recurrence not eligible for cisplatin: A single-center experience and literature review].
    Marques O; Brenet E; Gaultier V; Marchand-Crety C
    Cancer Radiother; 2023 Feb; 27(1):17-22. PubMed ID: 35853823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
    Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.